Barbara Gayle Duncan Halozyme Therapeutics, Inc. (HALO) insider trading activity
Barbara Gayle Duncan is of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 19,919 shares of HALO, which is worth approximately $1.13 Million. The most recent transaction as insider was on May 01, 2025, when has been sold 4,165 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
19.9K
26.44%
3M change
26.44%
12M change
Total Value Held
$1.13 Million
Barbara Gayle Duncan Transaction History
Also insider at
BGD
Barbara Gayle Duncan
Boston, MA